Skip to main content

Calcipotriene News

FDA Approves Sorilux for Adolescent Plaque Psoriasis

ADELAIDE, Australia, May 22, 2019 /PRNewswire/ – Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that the US Food and Drug Administration (FDA) has approved Sorilux (calcipotriene)...

Stiefel, a GSK company, Receives FDA Approval of Sorilux (calcipotriene) Foam, 0.005%

Research Triangle Park, N.C. – October 12, 2010 – Stiefel, a GSK company, today announced that the U.S. Food and Drug Administration (FDA) has approved Sorilux (calcipotriene) Foam, 0.005%, for the to...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Plaque Psoriasis, Psoriasis

Calcipotriene patient information at Drugs.com